Lymph Node Parameters Predict Adjuvant Chemoradiotherapy Efficacy and Disease-Free Survival in Pathologic N2 Non-Small Cell Lung Cancer

Pathologic N2 non-small cell lung cancer (NSCLC) is prominently intrinsically heterogeneous. We aimed to identify homogeneous prognostic subgroups and evaluate the role of different adjuvant treatments. We retrospectively collected patients with resected pathologic T1-3N2M0 NSCLC from the Shanghai C...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chen-Chen, Hou, Run-Ping, Feng, Wen, Fu, Xiao–Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484950/
https://www.ncbi.nlm.nih.gov/pubmed/34604073
http://dx.doi.org/10.3389/fonc.2021.736892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484950/
https://www.ncbi.nlm.nih.gov/pubmed/34604073
http://dx.doi.org/10.3389/fonc.2021.736892

Ejemplares similares